Carnexiv (carbamazepine) is an injectable formulation developed by Lundbeck for partial, generalised tonic-clonic seizures in adult patients who are unable to temporarily take oral medication.
Industry Report Store is an online comprehensive resource for market reports, analysis, news and expert commentaries. It enables access to primary and secondary research, extensive databases, industry surveys and analysis, plus the latest data on global and local markets. Data is gathered from a range of primary and secondary research sources, owned databases, surveys as well as insights and data from expert analysts.
Strategic intelligence reports for the healthcare industry
Industry Report Store also provides of a number of strategic intelligence reports specifically for the healthcare industry. These reports are published in house or by expert names such as Global Data, Technavio and GBI research. Reports provide an extensive and universal view of leading companies, as well as extensive reports for healthcare. A diverse range of market research reports are available relating to new advancements in technology, drug approval and growth worldwide. Industry Report Store encompasses categories such as biotech, pharma, equipment and services and main company profiles to ensure that the latest variety of information is readily available.
Reports cover a variety of integral global information and the types of reports available include:
- Market profiles, snapshots and guides
- Industry forecasts
- Monthly and annual deal reports
- Company profiles with SWOTs
- Survey reports and survey intelligence
Global healthcare and pharmaceutical market analysis
These publications provide an unparalleled analysis of market trends and their implications to help navigate, understand and capitalise on the opportunities in the global healthcare and pharmaceutical markets. The independent, comprehensive range of analysis, forecasts and data can help:
Industry Report Store
- Evaluate market opportunities and risks
- Monitor competitors and customers
- Assess the impact of changing regulations
- Plan and forecast budgets
- Stay up-to-date with recent industry developments and market trends
Visit the Industry Report Store website to browse all reports. Sample pages are also available on request for all reports on offer. If you have any questions about our reports or the contents, please do not hesitate to contact us.
Kovaltry (Anti haemophilic Factor VII (Recombinant)) is developed by Bayer as the treatment for children and adult patients with haemophilia A.